Heron Therapeutics (HRTX) Gross Profit (2017 - 2026)
Heron Therapeutics (HRTX) recorded Gross Profit of $26.09 million in Q2 2026, down 4.6% from $27.34 million a year earlier but up 8.4% from the prior quarter.
Powered by 
Analysis
Heron Therapeutics (HRTX) Gross Profit (2017 - 2026) Analysis & Trends
On a TTM basis, Heron Therapeutics' Gross Profit came in at $105.94 million as of Jun 30, 2026, down 5.2% year-over-year; for FY2025, it was $113.56 million, up 7.5% from FY2024.
- Annual Gross Profit has increased for five straight years, with a five-year compound annual growth rate of 58.9% (FY2020 to FY2025).
- Across earlier years, Gross Profit came in at $105.64 million in FY2024 (+70.6%), $61.94 million in FY2023 (+17.3%), $52.8 million in FY2022 (+30.9%) and $40.33 million in FY2021 (+259.6%).
- Quarterly Gross Profit has ranged from $9.71 million in Q4 2021 to $30.55 million in Q4 2024 over the past five years.
- On a year-over-year basis, Gross Profit has declined for three consecutive quarters, with growth averaging 13.6% over the last eight quarters.
- Peak year-over-year performance for Gross Profit in the last five years was growth of 119.8% in Q2 2024, against a decline of 20.9% in Q1 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $24.07 million (Q1 2026), $29.47 million (Q4 2025) and $26.3 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Heron Therapeutics | 70.40 Mn | -87.13 Mn | 26.29 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 26.29 Mn |
| Jun 30, 2026 | 26.09 Mn |
| Mar 31, 2026 | 24.07 Mn |
| Dec 31, 2025 | 29.47 Mn |
| Sep 30, 2025 | 26.30 Mn |
| Jun 30, 2025 | 27.34 Mn |
| Mar 31, 2025 | 30.45 Mn |
| Dec 31, 2024 | 30.55 Mn |
| Sep 30, 2024 | 23.35 Mn |
| Jun 30, 2024 | 25.51 Mn |
| Mar 31, 2024 | 26.23 Mn |
| Dec 31, 2023 | 24.35 Mn |
| Sep 30, 2023 | 13.23 Mn |
| Jun 30, 2023 | 11.60 Mn |
| Mar 31, 2023 | 12.76 Mn |
| Dec 31, 2022 | 17.40 Mn |
| Sep 30, 2022 | 11.84 Mn |
| Jun 30, 2022 | 11.46 Mn |
| Mar 31, 2022 | 12.10 Mn |
| Dec 31, 2021 | 9.71 Mn |
API Access
Heron Therapeutics Gross Profit API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-profit&ticker=HRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-profit", "ticker": "HRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-profit&ticker=HRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();